Clinical Trials Browser

INDUSTRY × Synovitis, Pigmented Villonodular × Tolbutamide × Clear all

NCT03291288 2021-05-14

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Phase 1 Completed

32 enrolled 22 charts

Synovitis, Pigmented Villonodular